We have located links that may give you full text access.
Journal Article
Multicenter Study
Observational Study
[Patient's care and management of dyslipidemia at discharge after an acute coronary syndrome in the clinical practice in Spain: The SINCOPA study].
Clínica e Investigación en Arteriosclerosis 2015 November
INTRODUCTION: European guidelines acknowledge that patients with an acute coronary syndrome (ACS) should have LDLc levels below 70mg/dL or reduced a 50% respect to their basal levels. However, some studies demonstrated that this goal is achieved in a small number of patients. The aim of this study was to determine how cardiologists (MC) and primary care specialist (GPs) from Spain manage LDLc in ACS patients during their daily practice.
METHODS: An observational, cross-sectional, multicentric study was conducted. Information about daily practice was obtained from 291 MC and 564 GPs across Spain.
RESULTS: 68% of MC and 67% of GPs considered ACS patients to be high-risk. Most consider the cLDL targets based on European guidelines. The statins most widely used for MC are atorvastatin and rosuvastatina and for GPs are atorvastatin and simvastatin. 66.4% of GPs follow the prescription of MC. 42% of MC and 19.9% of GPs considered that 75-100% of their patients achieved the LDLc target. The main reason of not achieving this target was lack of treatment adherence.
CONCLUSIONS: The lack of adherence and poor perception of real LDLc control may contribute to the failure in achieving lipid targets in ACS patients.
METHODS: An observational, cross-sectional, multicentric study was conducted. Information about daily practice was obtained from 291 MC and 564 GPs across Spain.
RESULTS: 68% of MC and 67% of GPs considered ACS patients to be high-risk. Most consider the cLDL targets based on European guidelines. The statins most widely used for MC are atorvastatin and rosuvastatina and for GPs are atorvastatin and simvastatin. 66.4% of GPs follow the prescription of MC. 42% of MC and 19.9% of GPs considered that 75-100% of their patients achieved the LDLc target. The main reason of not achieving this target was lack of treatment adherence.
CONCLUSIONS: The lack of adherence and poor perception of real LDLc control may contribute to the failure in achieving lipid targets in ACS patients.
Full text links
Related Resources
Trending Papers
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis.Alimentary Pharmacology & Therapeutics 2024 March 26
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app